FDA QMSR 2026 (21 CFR Part 820) & ISO 13485:2016: Medical Device Import Detention & 510(k) Checklist
Regulatory Bottom Line (BLUF)
Effective February 2, 2026, the FDA Quality Management System Regulation (QMSR) overhauled 21 CFR Part 820 by incorporating ISO 13485:2016 by reference and replacing legacy QSIT inspections with Compliance Program 7382.850. Having a 510(k) clearance alone does not shield an overseas factory from warning letters or port holds if post-clearance manufacturing controls fail QMSR audits.
Intelligence vs. Legal Counsel Boundary: DWPERadar provides public FDA Import Alert (DWPE), OASIS, Warning Letter, and Recall record cross-links for informational supplier vetting only—it does not conduct ISO 13485 registrar audits, certify QMSR conformity, or act as US legal counsel.
2026 Compliance Matrix & Detention Boundaries
| Control Area | 2026 Rule / Standard | Port Detention Trigger | Exclusion / Verification Limit |
|---|---|---|---|
| Quality Standard Framework | QMSR (21 CFR Part 820) incorporates ISO 13485:2016 with risk-management emphasis throughout design, supplier controls, and CAPA. | Legacy QSIT-only SOP binders lacking ISO 13485 risk traceability trigger CDRH Warning Letters and Import Alert holds. | An overseas ISO 13485 certificate from a third-party registrar does not exempt a factory from FDA Compliance Program 7382.850 inspections. |
| Pre-Market Clearance vs. Post-Market Manufacturing | Class II devices still require 510(k) substantial equivalence plus active establishment registration & device listing before US customs entry. | Unlisted SKUs or unapproved software/optical changes trigger NO_510K detentions regardless of factory ISO certifications. | 510(k) numbers belong to specific device indications; relabeling under Form FDA 766 cannot create a missing 510(k) clearance. |